1-2 of 2
Hans Smit, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1b Dose Escalation Study Of Oral Quisinostat, a Histone Deacetylase Inhibitor (HDACi), In Combination With Velcade (Bortezomib) and Dexamethasone For Patients With Relapsed Multiple Myeloma (MM)

Philippe Moreau, MD, Thierry Facon, MD, Cyrille Touzeau, MD, Lotfi Benboubker, MD, Martine Delain, MD, Julie Badamo-Dotzis, PhD, Charles Phelps, Christopher Doty, Hans Smit, PhD, Nele Fourneau, MD, Ann Forslund, Peter Hellemans, MD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1932.
https://doi.org/10.1182/blood.V122.21.1932.1932
Published: 2013
Journal Articles

Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP): Updated Results From a Phase 1b Study In Treatment-Naïve Patients With CD20-Positive B-Cell Non-Hodgkin’s Lymphoma (NHL)

Anas Younes, MD, Ian Flinn, MD, PhD, Jesus Berdeja, MD, Jonathan W. Friedberg, MD, Carla Casulo, MD, Catherine Thieblemont, MD, PhD, Franck Morschhauser, MD, PhD, Jason R. Westin, MD, Shobha Seetharam, PhD, Peter Hellemans, MD, Hans Smit, PhD, Ronald de Vries, MSc, Elisa Dauphinee, BSN, CRA, CCRP, Julie Badamo-Dotzis, PhD, Nele Fourneau, MD, Yasuhiro Oki, MD
Journal: Blood
Blood (2013) 122 (21): 852.
https://doi.org/10.1182/blood.V122.21.852.852
Published: 2013